ARIX BIOSCIENCE ORD 0.001P news, videos and press releases
For more news please use our advanced search feature.
ARIX BIOSCIENCE ORD 0.001P - More news...
ARIX BIOSCIENCE ORD 0.001P - More news...
- Scheme Effective
- Suspension of Trading in Shares
- Transaction Update
- Results of First General Meeting
- Holding(s) in Company
- Holding(s) in Company
- Update on the Scheme and Publication of Notice of Second General Meeting
- Update on the Scheme and Resignation of Directors
- Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
- Unaudited NAV for December 2023
- Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)
- Publication of Circular and RTW Bio Prospectus
- Holding(s) in Company
- Update regarding timing of Proposed Scheme of Reconstruction
- Unaudited NAV for November 2023
- Portfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial
- Correction: Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
- Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
- PDMR Notification & Director Shareholding
- Unaudited NAV for October 2023
- PDMR Notification & Director Shareholding
- PDMR Notification & Director Shareholding
- Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
- Portfolio company Harpoon Therapeutics announces up to $150 million private placement
- Unaudited NAV for September 2023
- Interim Results for the Six Months Ended 30 June 2023
- Board Change
- Notice of Results and Investor Presentation
- Unaudited NAV for August 2023
- Unaudited NAV for July 2023